Cargando…

NCBP1 enhanced proliferation of DLBCL cells via METTL3-mediated m6A modification of c-Myc

Diffuse large B-cell lymphoma (DLBCL) is malignant hyperplasia of B lymphocytes and standard care cannot satisfactorily meet clinical needs. Potential diagnostic and prognostic DLBCL biomarkers are needed. NCBP1 could bind to the 5ʹ-end cap of pre-mRNAs to participate in RNA processing, transcript n...

Descripción completa

Detalles Bibliográficos
Autores principales:	Meng, Sibo, Xia, Yuan, Li, Mingying, Wu, Yuyan, Wang, Dongmei, Zhou, Ying, Ma, Daoxin, Ye, Jingjing, Sun, Tao, Ji, Chunyan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10224985/ https://www.ncbi.nlm.nih.gov/pubmed/37244946 http://dx.doi.org/10.1038/s41598-023-35777-2

Ejemplares similares

METTL3 mediates chemoresistance by enhancing AML homing and engraftment via ITGA4
por: Li, Mingying, et al.
Publicado: (2022)

The effects of NCBP3 on METTL3‐mediated m6A RNA methylation to enhance translation process in hypoxic cardiomyocytes
por: Ye, Fei, et al.
Publicado: (2021)

mRNA export through an additional cap-binding complex consisting of NCBP1 and NCBP3
por: Gebhardt, Anna, et al.
Publicado: (2015)

HDAC1/3-dependent moderate liquid–liquid phase separation of YY1 promotes METTL3 expression and AML cell proliferation
por: Li, Meng, et al.
Publicado: (2022)

NCBP3 positively impacts mRNA biogenesis
por: Dou, Yuhui, et al.
Publicado: (2020)

The m6A Methyltransferase METTL3 Is Functionally Implicated in DLBCL Development by Regulating m6A Modification in PEDF
por: Cheng, Yingying, et al.
Publicado: (2020)

HBXIP promotes gastric cancer via METTL3-mediated MYC mRNA m6A modification
por: Yang, Zhi, et al.
Publicado: (2020)

Silencing of IRF8 Mediated by m6A Modification Promotes the Progression of T‐Cell Acute Lymphoblastic Leukemia
por: Zhou, Ying, et al.
Publicado: (2022)

The m(7)G Reader NCBP2 Promotes Pancreatic Cancer Progression by Upregulating MAPK/ERK Signaling
por: Xie, Jiancong, et al.
Publicado: (2023)

An NCBP3-Domain Protein Mediates Meiotic Silencing by Unpaired DNA
por: Boone, Erin C., et al.
Publicado: (2020)

NCBP2 and TFRC are novel prognostic biomarkers in oral squamous cell carcinoma
por: Arora, Rahul, et al.
Publicado: (2023)

Alternative splicing of METTL3 explains apparently METTL3-independent m(6)A modifications in mRNA
por: Poh, Hui Xian, et al.
Publicado: (2022)

Simultaneous CRISPR/Cas9‐mediated editing of cassava eIF4E isoforms nCBP‐1 and nCBP‐2 reduces cassava brown streak disease symptom severity and incidence
por: Gomez, Michael A., et al.
Publicado: (2018)

LncRNA AC098934 promotes proliferation and invasion in lung adenocarcinoma cells by combining METTL3 and m6A modifications
por: Huang, Shiqing, et al.
Publicado: (2022)

Immune checkpoint‐related gene polymorphisms are associated with acute myeloid leukemia
por: Wu, Yuyan, et al.
Publicado: (2023)

METTL3-dependent m(6)A modification programs T follicular helper cell differentiation
por: Yao, Yingpeng, et al.
Publicado: (2021)

METTL3-mediated m(6)A modification is required for cerebellar development
por: Wang, Chen-Xin, et al.
Publicado: (2018)

NCBP1 promotes the development of lung adenocarcinoma through up‐regulation of CUL4B
por: Zhang, Huijun, et al.
Publicado: (2019)

Mettl3-mediated m(6)A modification of Fgf16 restricts cardiomyocyte proliferation during heart regeneration
por: Jiang, Fu-Qing, et al.
Publicado: (2022)

Aberrant patterns of PET response during treatment for DLBCL patients with MYC gene rearrangements
por: Eertink, J. J., et al.
Publicado: (2021)

METTL3 Facilitates Oral Squamous Cell Carcinoma Tumorigenesis by Enhancing c-Myc Stability via YTHDF1-Mediated m(6)A Modification
por: Zhao, Wei, et al.
Publicado: (2020)

NCBP2 modulates neurodevelopmental defects of the 3q29 deletion in Drosophila and Xenopus laevis models
por: Singh, Mayanglambam Dhruba, et al.
Publicado: (2020)

Mitochondrial apoptosis-related gene polymorphisms are associated with responses to anthracycline-based chemotherapy in acute myeloid leukaemia
por: Meng, Guangqiang, et al.
Publicado: (2023)

Lkb1 aggravates diffuse large B-cell lymphoma by promoting the function of Treg cells and immune escape
por: Su, Xiuhua, et al.
Publicado: (2022)

Molecular basis for human mitochondrial tRNA m(3)C modification by alternatively spliced METTL8
por: Huang, Meng-Han, et al.
Publicado: (2022)

METTL3-mediated m(6)A modification of ZBTB4 mRNA is involved in the smoking-induced EMT in cancer of the lung
por: Cheng, Cheng, et al.
Publicado: (2020)

METTL3 Promotes the Progression of Gastric Cancer via Targeting the MYC Pathway
por: Yang, Dong-Dong, et al.
Publicado: (2020)

DARS-AS1 recruits METTL3/METTL14 to bind and enhance DARS mRNA m(6)A modification and translation for cytoprotective autophagy in cervical cancer
por: Zhu, Miaohua, et al.
Publicado: (2022)

Spatial single cell analysis of tumor microenvironment remodeling pattern in primary central nervous system lymphoma
por: Xia, Yuan, et al.
Publicado: (2023)

The M6A methyltransferase METTL3 promotes the development and progression of prostate carcinoma via mediating MYC methylation
por: Yuan, Yan, et al.
Publicado: (2020)

Homodimer-mediated phosphorylation of C/EBPα-p42 S16 modulates acute myeloid leukaemia differentiation through liquid-liquid phase separation
por: Wang, Dongmei, et al.
Publicado: (2023)

Role of MYC and BCL2 expression in a cohort of 43 patients with DLBCL: a retrospective study
por: Khan, Umair Tahir, et al.
Publicado: (2021)

The Immunology of DLBCL
por: Takahara, Taishi, et al.
Publicado: (2023)

METTL3-Dependent N6-Methyladenosine Modification Programs Human Neural Progenitor Cell Proliferation
por: Zhao, Yuan, et al.
Publicado: (2023)

Diagnostic and prognostic potential of the novel biomarker nuclear cap binding protein subunit 2 (NCBP2) in colon adenocarcinoma
por: Bu, He, et al.
Publicado: (2022)

METTL3-mediated m(6)A modification of TIMP2 mRNA promotes podocyte injury in diabetic nephropathy
por: Jiang, Ling, et al.
Publicado: (2022)

Molecularly Stratified Treatment Options in Primary Refractory DLBCL/HGBL with MYC and BCL2 or BCL6 Rearrangements (HGBL, NOS with MYC/BCL6)
por: Witte, Hanno M., et al.
Publicado: (2023)

ALKBH5-mediated N(6)-methyladenosine modification of TRERNA1 promotes DLBCL proliferation via p21 downregulation
por: Song, Wei, et al.
Publicado: (2022)

METTL3-Mediated m(6)A RNA Modification Regulates Corneal Injury Repair
por: Dai, Yarong, et al.
Publicado: (2021)

Mettl3-dependent m(6)A modification attenuates the brain stress response in Drosophila
por: Perlegos, Alexandra E., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_gkbuivru3bg0gr67u5aheh5mgn